5-aminolevulinic acid (5-ALA) is a prodrug that results in the fluorescence of high-grade gliomas relative to the surrounding brain parenchyma. 5-ALA has been increasingly utilized in fluorescence-guided surgery for these tumors, and its intraoperative use has been associated with a significantly improved extent of resection and progression-free survival.
5-aminolevulinic acid (5-ALA) is a prodrug that results in the fluorescence of high-grade gliomas relative to the surrounding brain parenchyma. 5-ALA has been increasingly utilized in fluorescence-guided surgery for these tumors, and its intraoperative use has been associated with a significantly improved extent of resection and progression-free survival.
This review outlines the growing body of evidence that has culminated in the recent Food and Drug Administration approval of 5-ALA, as well as emerging applications for this agent.
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| INTRODUCTION
High-grade gliomas (HGG), which account for 80% of primary malignant cerebral neoplasms, are aggressive tumors that require multimodal management. 1 Despite advancements in adjuvant chemo-and radiotherapy, the extent of initial resection remains one of the key factors influencing the prognosis for these patients. [2] [3] [4] [5] Because accurate intraoperative differentiation of the neoplastic tissue from normal parenchyma can be challenging, neurosurgeons have increasingly performed these surgeries under the guidance of tissue fluorescence. 6, 7 Preoperative administration of 5-aminolevulinic acid (5-ALA) results in highly specific accumulation of a fluorescent metabolite, protoporphyrin IX (PPIX), in malignant tissue, which allows for direct intraoperative visualization of tumor tissue. Substantially greater intracellular levels of PPIX have been observed in gliomas relative to the surrounding tissue, which has been attributed to several mechanisms. 11 The accumulation of PPIX within glioma cells involves reduced levels of the enzyme ferrochelatase and impaired cellular clearance by an ATP-binding cassette transporter (ABCB6). 12 The enzyme ferrochetalase catalyzes the addition of iron (Fe) to PPIX as the final step of the heme biosynthesis pathway, which is outlined in Figure 1 . 5-ALA induced fluorescence is also influenced by the vascularity of the tumor, blood-brain barrier (BBB) permeability, tumor cell proliferative activity, and cellular density. detection of HGGs resulted in a sensitivity of 85% and specificity of 82%. 13 The role of 5-ALA as a diagnostic tool has been demonstrated in series of both primary and recurrent HGGs, and appears to be effective regardless of prior management with radiotherapy or chemotherapy. 20 The findings of recent prospective studies regarding the utility of 5-ALA-guided resection of HGGs are summarized in Table 1. 14-16, [21] [22] [23] [24] [25] [26] [27] [28] As 
| FLUORESCENCE DETECTION/ INTENSITY
Although most published studies rely on observation and subjective associated with a higher WHO grade of tumor, indicating that spectroscopic probes may allow for intraoperative assessment of tumor malignancy. Unlike HGG, the low-grade tumors often do not emit sufficient fluorescence to allow the surgeon to visually discriminate tumor margins. 33 However, these tools for objective quantification of fluorescence have been shown to improve the sensitivity of 5-ALA for gliomas. 34, 35 This application also has potential value in the selection of tissue samples for biopsy collection. Suspected low-grade gliomas are often heterogeneous and may have focal sites within the tumor that demonstrate a higher grade of malignant transformation. 5-ALA has been utilized to identify these regions of increased malignancy within gliomas. 33 This may be valuable for obtaining representative samples and achieving accurate grading, which is essential for planning appropriate courses of adjuvant therapy.
| PHOTODYNAMIC THERAPY
Beyond its utility as an intraoperative diagnostic tool, 5-ALA has been increasingly evaluated for its direct therapeutic effects. When PPIX is exposed to laser emissions at a light wavelength of approximately 635 nm rather than 440 nm, it induces a phototoxic response by stimulating the release of reactive oxygen species. 11, 36 The resulting oxidative stress can cause cellular damage and induce cell death via apoptotic and necrotic pathways. 13, 37, 38 This technique, known as photodynamic therapy (PDT), has been identified as a potential treatment option for minimally invasive, localized destruction of cancerous lesions.
39
Although it is currently an off-label therapy, 5-ALA is particularly appealing as a PDT prodrug due to its high selectivity for tumor tissue, use for FGS, and its limited side effect profile relative to other photosensitizers. 36 In 
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